Muscle histochemistry in myotubular (centronuclear) myopathy
Related Experiment Videos
1Division of Ultrastructural Research, National Institute of Neuroscience, Tokyo, Japan.
Abstract:
We report the clinical and histochemical findings in 7 patients with myotubular (centronuclear) myopathy aged from 2 months to 32 years. The clinical symptoms varied from patient to patient. Three patients developed severe muscle weakness and hypotonia with respiratory distress from infancy, and 4 had muscle weakness from 2-5 years of age with no apparent delay in developmental milestones. In addition to an increased number of fibers with centrally placed nuclei, there were 3 other histochemical characteristics of this disorder, i.e., type 1 fiber predominance, type 1 fiber hypotrophy and type 2B fiber deficiency. Other histological findings included a peripheral halo in the sarcoplasm on NADH-TR staining and an increased number of undifferentiated type 2C fibers, indicating a delay in muscle fiber growth and differentiation due to a probable defective neural supply in the developing muscles.
Insights
Myotubular myopathy presents varied clinical symptoms and distinct histochemical features. Key findings include central nuclei, type 1 fiber changes, and type 2B fiber deficiency in affected individuals.
Area of Science:
- Neurology
- Muscle Biology
- Histopathology
Background:
- Myotubular myopathy (MTM) is a congenital myopathy characterized by muscle weakness.
- It is a rare genetic disorder affecting skeletal muscle development.
- Understanding its clinical and histochemical profile is crucial for diagnosis.
Purpose of the Study:
- To detail the clinical manifestations of myotubular myopathy.
- To identify key histochemical markers in affected muscle fibers.
- To correlate histological findings with clinical presentation in a cohort of patients.
Main Methods:
- Clinical assessment of 7 patients diagnosed with myotubular myopathy.
- Histochemical analysis of muscle biopsies, including NADH-TR staining.
- Evaluation of fiber type distribution (type 1, type 2B, type 2C) and nuclear positioning.
Main Results:
- Clinical variability observed, ranging from severe infantile hypotonia and respiratory distress to later onset muscle weakness.
- Histochemical findings consistently showed increased centrally placed nuclei.
- Additional characteristic features included type 1 fiber predominance, type 1 fiber hypotrophy, type 2B fiber deficiency, peripheral sarcoplasmic halos, and increased type 2C fibers.
Conclusions:
- Myotubular myopathy exhibits a spectrum of clinical severity.
- Specific histochemical patterns, including nuclear centralization and fiber type abnormalities, are diagnostic hallmarks.
- Findings suggest potential delays in muscle fiber maturation possibly linked to neural supply deficits.